Preview

Clinical and experimental thyroidology

Advanced search

The results of population neonatal screening for congenital hypothyroidism reflect the effect of iodine prophylaxes in Belarus

https://doi.org/10.14341/ket20106240-45

Abstract

Primary congenital hypothyroidism (CH) is the most common neonatal metabolic disorder and before the introduction of neonatal screening programs it was one of the most frequent causes of mental retardation. CH has the incidence of about 1:3000 newborns in different populations. In Belarus the population neonatal screening for CH has been performing since 1991. By the beginning of 2010 1320580 newborns were screened, and 201 cases of CH were diagnosed. The frequency of CH was estimated as 1:6570. The most common cause of CH in Belarus is thyroid hypoplasia. Neonatal thyroid stimulating hormone (TSH) level is a sensitive marker of iodine deficiency, so the neonatal screening results can be used for monitoring the population iodine prophylaxes programs. In 90-th, the primary positive rate in neonatal screening for CH was 0.65–5.2% for different regions of Belarus with cut-off level of 25 mIU/L. TSH level >5 mIU/L was noticed in 50% of screened newborns. In the 21-th century the number of primary positives diminished to 0.01–0.02% with cut-off level of 15 mIU/L. TSH level >5 mIU/L is noticed in 8.9% of screened newborns. The results of population neonatal screening for CH reflect the effectiveness of iodine prophylaxes programs run in Belarus in the 21-th century.

References

1. Loeber J.G. Neonatal screening in Europe; the situation in 2004 // J. Inherit Metab Dis / Published online: 6 July 2007. – DOI 10.1007/s10545-007-0644-5.

2. Delange F.M. Neonatal screening for congenital hypothyroidism: results and perspectives // Horm. Res. 1997. V. 48. P. 51–61.

3. Delange F.M. Screening for congenital hypothyroidism used as an indicator of IDD control // Thyroid. 1998. V. 8. P. 1185–1192.

4. Деланге Ф.М. Йодный дефицит в Европе – состояние проблемы на 2002 год / Все о щитовидной железе // Thyronet. Published online http://thyronet.rusmedserv.com/th_spec/thyr-103-2.html

5. Macchia P.E. Recent advances in understanding the molecular basis of primary congenital hypothyroidism // Molec. Med. Today. 2000. V. 6. P. 36–42

6. Park S.M., Chatterjee V.K.K. Genetics of congenital hypothyroidism // J. Med. Genet. 2005. V. 42. №5. P. 379–389.

7. Cултаналиева Р.Б., Нанаева Г.К., Дворкин М.И. и др. Уровень тиреотропинемии новорожденных как один из методов оценки и контроля йодной недостаточности // Вест. КРСУ. 2003. №7. С. 4.

8. WHO, UNICEF, and ICCIDD. Progress towards the elimination of Iodine Deficiency Disorders (IDD). Geneva: WHO, WHO/Euro/NUT, 1999. P. 1–33

9. Аринчин А.Н., Гембицкий М., Петренко С.В. и др. Зобная эндемия и йодная недостаточность у детей и подростков Республики Беларусь // Здравоохранение. 2000. №11. С. 25–30.

10. Indicators for Assessing Iodine Deficiency Disorders and their Control Through Salt Iodization. № 6 WHO/NUT. Geneva, 1994. P. 1–55.

11. Gerasimov G. Increasing iodine intake in populations through the use of iodized salt in bread baking // IDD Newsletter. 2009. N3. P. 9–12.

12. Мат. круглого стола “Оценка прогресса, достигнутого в Республике Беларусь в результате реализации программы предупреждения йоддефицитных заболеваний”, 24 марта 2010. Минск, 2010.


Review

For citations:


 ,  ,   The results of population neonatal screening for congenital hypothyroidism reflect the effect of iodine prophylaxes in Belarus. Clinical and experimental thyroidology. 2010;6(2):40-45. (In Russ.) https://doi.org/10.14341/ket20106240-45

Views: 639


ISSN 1995-5472 (Print)
ISSN 2310-3787 (Online)